HCG contamination of alglucerase: clinical implications in low-dose regimen.


Alglucerase (Ceredase) is currently the treatment of choice for patients with symptomatic Gaucher disease. The contamination of this placental enzyme with human chorionic gonadotropin (hCG) has raised concern regarding possible endocrinological complications. We examined 32 patients treated with low-dose alglucerase and 27 untreated patients as controls… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.